泰凌医药(01011.HK)：决定将公司转型为一间人工智能高科技医疗企业

Group 1 - The core viewpoint of the article is that Tai Ling Pharmaceutical (01011.HK) is transitioning from a traditional pharmaceutical company to an artificial intelligence high-tech medical enterprise to adapt to market changes and the widespread application of AI in healthcare [1] Group 2 - The company has been operating in the healthcare sector for 30 years, indicating a strong foundation and extensive management experience [1] - The board of directors has made a careful decision to implement this transformation and has developed a future development strategy [1]